Company Filing History:

15 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2002-2009

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7598386 - Sulphones which modulate the action of gamma-secretase (2009-10-06),

2. 7595344 - Sulphones which modulate the action of gamma secretase (2009-09-29),

3. 7410964 - Cyclohexyl sulphones as gamma-secretase inhibitors (2008-08-12),

4. 7393858 - Tetrahydropyran compounds as tachykinin antagonists (2008-07-01),

5. 7342009 - Cyclic sulfonamides for inhibition of gamma-secretase (2008-03-11),

6. 7304094 - Cyclohexyl sulphones (2007-12-04),

7. 7276637 - Synthesis of cyclohexanone derivatives (2007-10-02),

8. 7265110 - Tetrahydropyran derivatives and their use as therapeutic agents (2007-09-04),

9. 7253205 - Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents (2007-08-07),

10. 7105507 - Cyclohexane derivatives and their use as therapeutic agents (2006-09-12),

11. 7101895 - Cyclohexyl sulphone derivatives as gamma-secretase inhibitors (2006-09-05),

12. 6984663 - Cyclohexyl sulphones (2006-01-10),

13. 6953792 - Cyclohexyl derivatives and their use as therapeutic agents (2005-10-11),

14. 6890956 - Cyclohexyl sulphones as gamma-secretase inhibitors (2005-05-10),

15. 6518273 - 2-aryl indole derivative as antagonists of tachykinins (2003-02-11),

Title: The Innovations of Duncan Edward Shaw

Introduction

Duncan Edward Shaw is a notable inventor based in Bishops Stortford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical biological processes. With a total of 16 patents to his name, Shaw's work has the potential to impact the treatment of Alzheimer's disease.

Latest Patents

Shaw's latest patents include innovative sulphones that modulate the action of gamma-secretase. These novel sulphones, described by a specific formula, are designed to influence the activity of gamma-secretase, making them valuable in the treatment or prevention of Alzheimer's disease. The compounds are aimed at providing therapeutic options for individuals affected by this debilitating condition.

Career Highlights

Throughout his career, Duncan Edward Shaw has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Shaw has collaborated with notable colleagues such as Kevin Dinnell and Timothy Harrison. These partnerships have likely facilitated the exchange of ideas and expertise, enhancing the quality and impact of his work.

Conclusion

Duncan Edward Shaw's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing critical health challenges. His work, particularly in the area of Alzheimer's disease, highlights the importance of research and innovation in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.